(Reuters) - Shares of Complete Genomics Inc continued their rally on Thursday, jumping 11 percent in premarket trading after the gene sequencing company unveiled a technology that is expected to improve accuracy and reduce the amount of DNA needed for testing. The new technology, named Long Fragment Read (LFR), will result in a 10-fold increase in accuracy, Complete Genomics said in a statement late on Wednesday. The shares rose 49 percent after the announcement. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment